Brief: Prophase Labs Announces Formation Of Prophase Biopharma Inc (PBIO) For The Licensing And Development Of Novel Drugs, Compounds And Biotechnology

Prophase Labs

28/06/2022 13:36

June 28 (Reuters) - Prophase Labs Inc  PRPH.O :
    * PROPHASE LABS ANNOUNCES FORMATION OF PROPHASE BIOPHARMA,
INC.
(PBIO) FOR THE LICENSING AND DEVELOPMENT OF NOVEL DRUGS,
COMPOUNDS AND BIOTECHNOLOGY
    * PROPHASE LABS - ANNOUNCES FIRST LICENSING AGREEMENT FOR
PBIO
WITH GLOBAL BIOLIFE, FOR BROAD BASED ANTI-VIRAL FIGHTING
COMPOUNDS EQUIVIR AND EQUIVIR G
    * PROPHASE LABS INC - UNDER AGREEMENT, CO HAS OBTAINED
EXCLUSIVE
RIGHTS WORLDWIDE TO DEVELOP AND COMMERCIALIZE EQUIVIR AND
EQUIVIR G
    * PROPHASE-WILL COORDINATE WITH GLOBAL BIOLIFE TO WORK WITH
CHARLES RIVER LABS TO COMPLETE PRODUCT TESTING COVERING
BIOAVAILABILITY, STABILITY & SAFETY

Source text for Eikon:  ID:nGNXc87bmK 
Further company coverage:  PRPH.O